肿瘤预防与治疗2024，Vol.37Issue(4)：292-300,9.DOI:10.3969/j.issn.1674-0904.2024.04.004
2018年四川省肿瘤医院食管癌外科手术治疗数据报告
Annual Data Report on Surgical Treatment of Esophageal Cancer in Si-chuan Cancer Hospital in 2018
摘要
Abstract
Objective:To provide reference values for the surgical treatment and multidisciplinary treatment of esophageal cancer in China through analyzing the data of esophageal cancer treated by standardized surgery and multidisciplinary treat-ment in Sichuan Cancer Hospital in 2018.Methods:We retrospectively analyzed 265 esophageal cancer patients treated through standardized surgical treatment and multidisciplinary treatment in Sichuan Cancer Hospital in 2018 and analyzed their tumor biological characteristics and postoperative long-term effects.Results:The patients with esophageal cancer were main-ly in 60～69 years old(45.7％),including 220 males and 45 females,among them,263 cases underwent esophagectomy and 2 cases underwent endoscopic submucosal dissection.Postoperative pathological results of all patients were squamous cell carcinoma.136 cases(51.3％)had their tumors located in the mid-thoracic segment.64 cases(24.2％)received neoad-juvant therapy,and 199 cases(75.1％)opted for direct surgery.McKeown procedure was performed in 240 patients(90.6％),minimally invasive surgery in 238 patients(90.5％).The average number of dissected lymph nodes was 21± 12,and the mean number of lymph node stations dissected was 7±2.Sixty-one patients(23.0％)received adjuvant therapy after surgery.The R0 resection rate was 98.5％(261/265).The 1-,3-and 5-year overall survival rate after R0 resection were 85.8％,63.6％and 54.4％,respectively.The 1-,3-and 5-year disease-free survival rate after R0 resection were 79.1％,60.4％and 52.1％,respectively.Conclusion:R0 resection and standardized lymph node dissection can be a-chieved through standardized surgical treatment and multidisciplinary treatment.Patients with esophageal cancer can therefore obtain more satisfactory long-term survival.关键词
食管癌/食管切除术/多学科治疗/年度报告Key words
Esophageal cancer/Esophagectomy/Multidisciplinary treatment/Annual report分类
临床医学引用本文复制引用
熊继承,冷雪峰,陆思秒,谢钦,彭林,方强,肖文光,乔良,缪艳,韩泳涛..2018年四川省肿瘤医院食管癌外科手术治疗数据报告[J].肿瘤预防与治疗,2024,37(4):292-300,9.基金项目
This study was supported by National Key Research and Development Program of China(No.2022YFC2403400),and by grants from Science and Technology Department of Sichuan Province(No.国家重点研发计划(编号:2022YFC2403400) （No.2022YFC2403400）
四川省科技厅重点研发项目(编号:2023YFS0044) （编号:2023YFS0044）
四川省国际科技创新合作项目(编号:2020YFH0169) （编号:2020YFH0169）
吴阶平医学基金会临床科研专项资助基金(编号:320.6750.2020-15-3) （编号:320.6750.2020-15-3）
四川省临床重点专科建设项目([2022]70)2023YFS0044,No.2020YFH0169),Wu Jieping Medical Foundation(No.320.6750.2020-15-3)and Health Commission of Sichuan Province(No.[2022]70). （[2022]70）
